Plasma cell dyscrasia is found among people who take Clobetasol Propionate, especially for people who are female, 60+ old also take medication Prednisone, and have Multiple myeloma . We study 2,138 people who have side effects while taking Clobetasol propionate from FDA and social media. Among them, 9 have Plasma cell dyscrasia. Find out below who they are, when they have Plasma cell dyscrasia and more.
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>
Clobetasol propionate has active ingredients of clobetasol propionate. It is often used in psoriasis. (latest outcomes from Clobetasol propionate 2,306 users)
Plasma cell dyscrasia (cancers of the plasma cells) has been reported by people with thrombocytopenia, acute kidney failure, urinary tract infection, diarrhea, general physical health deterioration (latest reports from 86,046 Plasma cell dyscrasia patients).
On Aug, 28, 2016
2,138 people reported to have side effects when taking Clobetasol Propionate.
Among them, 9 people (0.42%) have Plasma Cell Dyscrasia
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Fever up to 100f. Hb =9.8 in spite of taking hb improvement medicines since two months. Ldh>1000. Flc kappa slightly high at 25.4. Alpha 1 globulin at 1.1(normal .2-.4) . Sudden rise in bp at 177/80. Bone fracture at d12. Spondlylolisthesis at L5. Tb, ra,thyroid ruled out, weight loss . Doctors ...
Had 1 dose of melphan before stem cell transplant and developed excrutiating peripheral neuropathy with edema of feet. As a result, am unable to ambulate. Had no neuropathy or difficulty ambulating prior to this medication and stem cell transplant. Was prescribed gadopentin for treatment of ...
Hi, my name is Mathew. I come from Poland. My father has Multiple Myeloma from 2014. He has chemotherapy and than autograft. After it myeloma "dissapear" but not for long time. On may 2016 myeloma come backs. He gets Revlimid but after almost 2 months it doesn't works. We tried to find why it ...
My mother has multiple myloma. I believe she is in the last stages. She is not going to do any more radiation and has opted out of chemotherapy. I'm wondering about some of her development stages. The doctors think that she will have hospice with in a month or so. Trying to find out as much ...
My little brother passed away almost three years ago from complications from multiple myeloma. He was 51 at the time of his death. Very fit, sometimes over weight, never smoked. He had taken lamasil a few years prior to being diagnosed. The Lamasil made him kinda sick to his stomach, but he ...
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.